Clinical trial
Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients (ASSERT-AF)
NCT04818645 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients (ASSERT-AF)
- Lead sponsor
- University of Rochester
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 31, 2023
- Completion date
- July 1, 2028
- Enrollment
- 477 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.